Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 555 Specimen Handling 459 Carboplatin 446 Magnetic Resonance Spectroscopy 427 Cyclophosphamide 412 Cisplatin 404 Gemcitabine 314 Radiotherapy 313 Bevacizumab 310 Paclitaxel 300 Biopsy 260 Drug Therapy 252 Capecitabine 241 Oxaliplatin 240 fludarabine 236 Nivolumab 226 venetoclax 225 Injections 214 Docetaxel 203 Fluorouracil 201 Dexamethasone 186 Radiosurgery 172 Rituximab 161 Pemetrexed 157 durvalumab 144 Standard of Care 143 atezolizumab 139 toripalimab 137 tislelizumab 137 Leucovorin 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × fluarix × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡